Literature DB >> 6218433

Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures.

B J Davidson, B L Riggs, H W Wahner, H L Judd.   

Abstract

Vertebral fractures due to osteoporosis commonly occur in postmenopausal women. Levels of cortisol and sex steroids in the circulation vary among older women. It has been suggested that this variation may contribute to the occurrence of osteoporotic fractures in some subjects but not others. To examine this, 30 patients with osteoporotic spinal fractures were compared to an equal number of controls matched to the patients for age and years since menopause. All subjects had intact ovaries and had not taken estrogen replacement therapy for more than 3 months during their entire lifetime. Spinal bone mineral density determined by dual photon absorptiometry was significantly lower (P less than .01) in the fraction group (0.75 +/- 0.03 g/cm2) than in the controls (1.0 +/- 0.03 g/cm2). No significant differences in body habitus or cortisol and sex steroid levels (both total and free) were found, with the exception of total estradiol levels, which were 16% higher in the fracture patients. This difference was presumably coincidental as there was no difference of free estradiol levels between groups. It is concluded that factors other than the differences of endogenous cortisol and sex steroid levels present in these postmenopausal women were responsible for the reduced bone mineral density of the spine observed in the fracture patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6218433

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

1.  Endogenous sex hormones and bone mineral density among community-based postmenopausal women.

Authors:  S Murphy; K T Khaw; M J Sneyd; J E Compston
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

2.  Androgens regulate bone resorption activity of isolated osteoclasts in vitro.

Authors:  L Pederson; M Kremer; J Judd; D Pascoe; T C Spelsberg; B L Riggs; M J Oursler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Bone mineral density in Addison's disease.

Authors:  J P Devogelaer; J Crabbé; C Nagant de Deuxchaisnes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

4.  The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.

Authors:  B J Riis; P Rødbro; C Christiansen
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

Review 5.  Androgens and bone.

Authors:  D Vanderschueren; R Bouillon
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

Review 6.  That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.

Authors:  T G Palferman
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

Review 7.  DHEA and the skeleton (through the ages).

Authors:  C M Gordon; J Glowacki; M S LeBoff
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

8.  Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).

Authors:  Jane A Cauley; Michelle E Danielson; Guru Rajesh Jammy; Doug C Bauer; Rebecca Jackson; Jean Wactawski-Wende; Rowan T Chlebowski; Kristine E Ensrud; Robert Boudreau
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

9.  Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency.

Authors:  B Lawrence Riggs; Sundeep Khosla; Elizabeth J Atkinson; Colin R Dunstan; L Joseph Melton
Journal:  Osteoporos Int       Date:  2003-07-18       Impact factor: 4.507

10.  Sex steroids and bone mass. A study of changes about the time of menopause.

Authors:  C Slemenda; S L Hui; C Longcope; C C Johnston
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.